Erectile Dysfunction Statistics 2026: How Common Is ED?

Erectile dysfunction is one of the most common health conditions in men. The most-cited estimate, from the Massachusetts Male Aging Study (MMAS), found that about 52% of men aged 40 to 70 experience some degree of ED - and prevalence climbs steeply with age, risk factors and overall health. If you have it, you are emphatically not alone; you're in the majority among middle-aged and older men, and in large company among younger ones.

Here's the honest nuance behind that headline, because the single number hides a lot. "Some degree of ED" spans everything from occasional mild difficulty to complete inability, so the 52% figure bundles mild, moderate and complete cases together. The share with moderate-to-complete ED is lower - but still rises sharply with age. And estimates vary widely between studies (from as low as 3% to as high as 76% in different populations) depending entirely on how researchers define and measure ED, and who they study.

This guide lays out the real numbers - by age, by country, and by the health conditions that drive ED - all sourced to the actual research, with the usual caveats about where estimates diverge. The goal isn't to alarm you; the data is reassuring in two ways. First, ED is normal and common, not a personal failing. Second, and most important, it's highly treatable for the large majority of men. Let's look at what the numbers actually say.

The most important erectile dysfunction statistics, in one place - each sourced and unpacked in the sections below:

• ~52% of men aged 40-70 have some degree of ED (Massachusetts Male Aging Study).
• Prevalence rises with age from roughly 5-15% in younger men to about 70% in men over 70.
• ~1 in 4 men seeking help for new ED are under 40 - and nearly half of those young men have severe ED.
• ~26 new cases of ED per 1,000 men each year (MMAS incidence data).
• ~65.8% estimated prevalence of ED in men with diabetes (global umbrella review).
• >90% prevalence of ED in men with coronary artery disease; ~62% after a heart attack.
• Smoking roughly doubles the odds of moderate-to-complete ED.
• Obesity raises ED risk by an estimated 30-90%.
• An older but widely-cited projection estimated ~322 million men worldwide would have ED by 2025, up from ~152 million in 1995.
• The hopeful one: ED is treatable for the large majority of men - yet many never seek help.

Every figure above is explained, sourced and contextualized below - including why ED statistics vary so much between studies, and what the numbers actually mean for you.

There's no single precise global count, but the most-cited projection estimated roughly 322 million men worldwide would have ED by 2025, up from about 152 million in 1995 - and recent systematic reviews estimate that 20% to 50% of adult men in the general population are affected. The honest headline is "hundreds of millions," with real uncertainty around the exact number.

Why the range is so wide:

• The 322 million by 2025 figure comes from a projection published decades ago. It's been repeated so often it's treated as fact, but it's an aging estimate, and its target year has now passed - treat it as a historical ballpark, not a current census.
• A King's College London review of global studies found prevalence estimates ranging from 3% to 76.5% - an enormous spread that mostly reflects differences in the ages studied, the definitions used, and how ED was measured.
• A more recent 2010-2024 systematic review landed on roughly 20-50% of adult men in the general population.

The takeaway isn't a tidy number - it's that ED affects a vast share of the world's men, somewhere in the hundreds of millions, and that the "true" figure depends heavily on how you count. What's not in doubt is the scale: this is one of the most prevalent conditions in men's health globally, and demand for treatment is enormous. For how that plays out in practice, see our complete guide to online ED treatment.

In the US, large surveys estimate ED affects roughly 12-18% of men under 45, rising to about 48% of men aged 65-74 and around 52% of men 75 and older - with the overall adult figure commonly placed in the tens of millions. American data largely tracks the global age pattern: uncommon-but-real in younger men, majority-level in the oldest groups.

Some anchors from US data:

• The Massachusetts Male Aging Study (MMAS) - the benchmark US dataset - found about 52% of men aged 40-70 had some degree of ED, with age the single strongest correlate.
• NHANES (the nationally-representative US health survey) first collected ED data in the early 2000s using the same self-report measure as MMAS, making the two broadly comparable.
• Survey breakdowns commonly show prevalence climbing from roughly 12-18% under age 45 to ~48% at 65-74 and ~52% at 75+.

One caveat worth flagging: much of the most-cited US prevalence data comes from studies that are now a couple of decades old, and newer nationally-representative releases are limited. So the precise percentages should be read as well-established ballparks rather than fresh 2026 counts. The broad picture, though, is stable and consistent across datasets: ED is common in American men and becomes the norm with age. If it's affecting you, you're part of a very large group - and an even larger one that's treatable.

Age is the strongest single predictor of ED. Prevalence rises consistently decade by decade - and understanding the by-age numbers is the most useful way to put your own situation in context. Here's the picture the research supports, pulled together from MMAS and major reviews:

Figures are approximate and vary by study, definition and population; "some degree" of ED (mild + moderate + complete) runs higher than "moderate-to-complete" alone, which is why ranges overlap.

A few honest notes on reading this table. First, the ranges are wide because different studies define and measure ED differently - a study counting any difficulty will report higher numbers than one counting only significant ED. Second, these are population averages; plenty of 70-year-olds have no ED and some 30-year-olds do. Third, and encouragingly, prevalence rising with age doesn't mean ED is an untreatable part of aging - treatment works across the age range. The clearest pattern is simply that erectile function tracks vascular and overall health, which decline gradually with age for most men.

The "rule of decades" is a rough clinical shorthand from the Massachusetts Male Aging Study: the approximate percentage of men with ED loosely corresponds to their age by decade - so around 40% of men in their 40s, 50% in their 50s, 60% in their 60s, and 70% in their 70s have some degree of ED. It's a memory aid, not a precise law, but it captures the core trend well.

How to use it sensibly:

• It's a loose approximation, not an exact measurement - real study numbers vary around it, and the definition of "ED" moves the figures.
• It describes "some degree" of ED (including mild cases), not severe ED, which is less common at every age.
• Its real value is normalizing the experience: if roughly half the men your age (in your 50s) have some ED, it reframes the condition from "something is uniquely wrong with me" to "this is a common, expected, treatable part of male health."

That reframing matters more than the exact math. A huge barrier to men getting help for ED is the false belief that it's rare or shameful. The rule of decades - imperfect as it is - makes the point that ED is statistically ordinary, especially with age. The right response to "lots of men my age have this" isn't resignation; it's the opposite - because the same decades of research that show how common ED is also show how treatable it is. Our best ED treatment guide covers the options.

More common than the stereotype suggests. General-population estimates put ED in men under 40 at roughly 5-10%, but among men actually seeking help for new ED, about 1 in 4 (26%) are 40 or younger - and nearly half of those young men have severe ED. The idea that ED is purely an older man's problem is simply not supported by the data.

The key figures:

• A widely-cited 2013 study in the Journal of Sexual Medicine (Capogrosso and colleagues) found that 26% of men presenting for newly-diagnosed ED were 40 or younger, and that 48.8% of those young men had severe ED - a rate similar to the older group.
• General-population prevalence for men aged 20-39 is often estimated around 5%, though some reviews put it higher.
• Reviewers increasingly argue ED in younger men is underestimated and possibly rising.

There's an important difference in cause, though, which the statistics alone don't show: young-men ED is more often psychological (performance anxiety, stress, depression), lifestyle-related, or medication-related than driven by the vascular disease behind most older-man ED - which also makes it highly treatable. If you're a younger man, our dedicated guide to erectile dysfunction in young men covers the causes and fixes specific to your age group. The headline statistic for you: you are far from alone, and the odds of a treatable cause are excellent.

ED rises with age mainly because erections depend on healthy blood vessels, and vascular health gradually declines with age and accumulated risk factors - not because aging "switches off" sexual function. The age statistics are really blood-vessel statistics in disguise.

The drivers behind the by-age numbers:

• Vascular aging. Arteries stiffen and narrow over time, and the small penile arteries - among the first to show this - deliver less of the blood flow an erection needs.
• Accumulating conditions. High blood pressure, diabetes, high cholesterol and heart disease all become more common with age, and each independently raises ED risk.
• Falling testosterone. Testosterone declines gradually with age, which can affect desire and, for some men, function.
• More medications. Older men take more drugs, some of which (certain blood-pressure medicines, antidepressants) can contribute to ED.

The useful implication is that age itself isn't the real enemy - vascular and metabolic health is. That's why two men the same age can have completely different erectile function, and why the things that protect your blood vessels (exercise, not smoking, managing weight, blood sugar and blood pressure) also protect your erections. It's also why ED at any age is worth investigating rather than writing off as "just getting older" - the underlying cause is often treatable, and sometimes an early signal of something worth catching. See what causes erectile dysfunction for the full picture.

Not all ED is the same, and the statistics change dramatically depending on which severity you count. In the Massachusetts Male Aging Study, that overall ~52% figure for men 40-70 broke down roughly into mild, moderate and complete categories - with complete (total) ED the least common and rising most steeply with age. This is why a single prevalence number can be misleading.

How severity is typically categorized:

• Mild ED: occasional difficulty; often situational. The largest share of "some degree of ED," and frequently the most reversible.
• Moderate ED: more consistent difficulty getting or keeping an erection.
• Complete (severe) ED: the inability to achieve an erection sufficient for sex most or all of the time. Less common overall, but its prevalence climbs sharply with age - in MMAS, complete ED rose from around 5% at age 40 toward roughly 15% by age 70.

Why this matters for reading any statistic: a headline like "52% of men have ED" includes a lot of mild, occasional cases. The share of men with the severe, every-time version is considerably smaller - which is both more honest and more reassuring. It also matters for treatment: mild ED often responds to lifestyle changes and first-line pills, while severe ED may need a more layered approach. When you see an ED prevalence number anywhere, the first question to ask is "what severity are they counting?" - because that single choice can double or halve the figure.

The evidence suggests ED - especially in younger men - may be rising, though some of the apparent increase reflects better awareness, more men seeking help, and rising rates of the conditions that cause ED (obesity, diabetes) rather than a pure biological shift. It's a real trend to watch, with honest uncertainty about how much is genuine versus better-measured.

What points toward a real increase:

• Rising metabolic disease. Obesity and type 2 diabetes - two of the strongest ED risk factors - have climbed for decades, and they're appearing in younger people. More metabolic disease plausibly means more ED.
• Younger-men signal. Researchers increasingly report that ED in men under 40 is more common than historically assumed, and some argue it's genuinely increasing.
• Lifestyle factors - sedentary routines, poor sleep, chronic stress - are widespread.

What complicates the picture:

• More awareness and help-seeking. Telehealth and destigmatization mean more men report and treat ED than a generation ago - which can look like rising prevalence even if the underlying rate is stable.
• Measurement changes. Different surveys and definitions make trends hard to compare cleanly.

The honest read: ED is at least as common as ever, is being recognized far more, and the metabolic-disease trends suggest the underlying burden is probably growing - particularly in younger men. Either way, the practical response is the same: it's common, it's treatable, and the health factors driving it are worth addressing for far more than your sex life.

Diabetes is one of the strongest risk factors for ED by the numbers: a global umbrella review estimated ED prevalence at about 65.8% in men with diabetes, and other sources put it in the 35-75% range - versus roughly 26% in the general population. Risk rises with how long a man has had diabetes and how poorly it's controlled. If you have diabetes, ED is common enough that it's almost expected - and important to address.

The data:

• Pooled global prevalence of ED in diabetic men: approximately 65.8% (umbrella review).
• Other estimates: 35-75% of diabetic men, compared with about 26% in men without diabetes.
• Risk increases with longer duration of diabetes and higher HbA1c (worse blood-sugar control).
• Diabetic men also tend to develop ED earlier and more severely than non-diabetic men.

The mechanism explains the numbers: diabetes damages both the small blood vessels and the nerves erections depend on. The encouraging flip side is that better blood-sugar control, weight loss and cardiovascular health protect those tissues - making diabetic ED one of the more preventable and improvable forms. If you have diabetes and ED, the highest-value move is optimizing the diabetes itself, alongside proven ED treatment. The intersection of metabolic health and erections - including the newer weight-loss drugs - is covered in our guide to GLP-1 drugs and erectile dysfunction.

The ED-heart connection is striking in the data: ED prevalence exceeds 90% in men with coronary artery disease and is around 62% in men after a heart attack - and ED often appears years before cardiac symptoms, which is why doctors treat it as an early warning sign of cardiovascular disease. This is the most clinically important statistic in this whole guide.

The numbers:

• ED prevalence in men with coronary artery disease: over 90%.
• ED prevalence after a heart attack: about 62%.
• ED frequently precedes cardiovascular symptoms by several years - commonly cited as a roughly 3-5 year lead time - because the small penile arteries show damage before the larger coronary arteries do.
• ED and heart disease share the same risk factors: high blood pressure, diabetes, high cholesterol, obesity, smoking and inactivity.

The practical meaning is serious and worth stating plainly: new ED, especially in a younger or middle-aged man, can be the body's first visible sign of vascular trouble that also threatens the heart. That's not a reason to panic, but it is a strong reason to get evaluated - a simple check of blood pressure, blood sugar and cholesterol can either reassure you or catch something important early, while it's easy to address. Treating ED as a useful health signal, rather than just a bedroom nuisance, is genuinely one of the smartest things a man can do with the information.

Carrying excess weight substantially raises ED risk: estimates suggest obesity increases the likelihood of ED by roughly 30-90%, and waist circumference is a better predictor of that risk than BMI. Obesity sits at the center of the metabolic web that drives so much ED.

The data and mechanisms:

• Obesity is estimated to raise ED risk by 30-90%, and it's an independent cardiovascular risk factor in its own right.
• Waist circumference (central/belly fat) predicts ED risk more reliably than overall BMI - visceral fat is the metabolically harmful kind.
• Excess fat lowers testosterone, promotes inflammation, worsens blood-vessel function, and drives the diabetes and blood-pressure problems that independently cause ED.

The hopeful counterpart to these numbers is some of the strongest data in the field: weight loss improves erections. A landmark randomized trial found that a meaningful share of obese men with ED regained normal erectile function through sustained weight loss and increased activity - no medication required. So while obesity statistics for ED are sobering, they also point to one of the most effective and health-positive interventions available. For a man carrying extra weight, losing it is arguably the highest-value "ED treatment" there is - and it protects his heart at the same time. Our natural ED remedies guide covers the lifestyle evidence.

Smoking is a clear, dose-dependent ED risk factor: studies find that smoking roughly doubles the odds of moderate-to-complete ED, and one meta-analysis-based figure puts the increased risk from current smoking at about 51%. For a function that's fundamentally about blood flow, inhaling a vasoconstrictor is a direct problem.

The numbers:

• One follow-up study found smoking almost doubled the likelihood of moderate or complete ED.
• A meta-analysis-based estimate attributes a roughly 51% increased risk of ED to current smoking.
• The risk is dose-dependent - more cigarettes and more years of smoking mean higher risk.

The mechanism is straightforward: nicotine acutely constricts blood vessels, and the broader chemical load of smoking damages the vessel lining over time, impairing the ability of penile arteries to dilate and fill. The genuinely good news in the data: quitting helps, and younger men's blood vessels are often resilient enough to recover meaningfully - studies of men who quit smoking have found improvements in erectile function. If you smoke and have ED, quitting is one of the highest-value things you can do, for your erections and your entire cardiovascular system. Vaping delivers the same nicotine and the same acute vasoconstriction, so it should be treated as a likely contributor too, even though its long-term ED data is thinner.

Beyond diabetes and obesity, the other cardiovascular risk factors all raise ED prevalence: high blood pressure, high cholesterol and metabolic syndrome each independently increase the odds of ED, and they cluster together - so many men with ED have several at once. ED is, statistically, a condition of the whole vascular system.

What the research links to higher ED rates:

• High blood pressure (hypertension) damages blood vessels over time and is consistently associated with higher ED prevalence - and some blood-pressure medications (notably older diuretics and beta-blockers) can themselves contribute to ED.
• High cholesterol / dyslipidemia promotes the arterial narrowing that reduces penile blood flow.
• Metabolic syndrome - the cluster of abdominal obesity, high blood pressure, high blood sugar and abnormal cholesterol - is strongly associated with ED, with risk rising as more components are present.

The through-line across every risk factor in this guide is the same: ED is overwhelmingly a vascular and metabolic condition. That's why the statistics for diabetes, heart disease, obesity, smoking, blood pressure and cholesterol all point the same direction, and why they overlap in the same men. It's also why the single most powerful thing most men can do for their erections long-term isn't a pill - it's improving the cardiovascular health those pills are compensating for. The pill handles tonight; better vascular health handles the years.

Psychological factors are a major driver of ED, especially in younger men: depression and anxiety are strongly associated with erectile difficulty, and performance anxiety is considered the single most common cause of ED in young men. The vascular story dominates older-man ED; the psychological story dominates younger-man ED.

What the evidence shows:

• Depression is consistently linked to higher ED rates, through both brain chemistry (blunted desire and arousal) and behavior - and, awkwardly, many antidepressants (SSRIs) commonly cause sexual side effects themselves.
• Anxiety, particularly performance anxiety, directly blocks erections by triggering the fight-or-flight response, which constricts the arteries an erection needs.
• In younger men, psychological causes are thought to account for a large share of ED - often the majority - which is part of why young-men ED is so treatable.
• The relationship runs both ways: ED causes distress and relationship strain, which worsen the anxiety and depression that caused it - a cycle that treatment can break.

The practical upshot of these numbers: for a lot of men - especially younger ones - ED isn't primarily a plumbing problem, it's a nervous-system and mood problem, and treating the anxiety or depression (and sometimes using short-term medication to break the cycle) resolves it. If this sounds like your situation, our guide to ED in young men goes deep on the psychological causes and how to fix them.

Low testosterone contributes to some ED, but it's a less common primary cause than the vascular and psychological drivers - and importantly, low testosterone more often reduces desire (libido) than directly causing a mechanical erection failure. The statistics here are frequently overstated by testosterone-clinic marketing, so it's worth being precise.

What's accurate to say:

• Genuinely low testosterone can contribute to reduced libido, fatigue, low mood and, for some men, erectile difficulty.
• But many men with ED have normal testosterone, and many men with low testosterone have normal erections - the overlap is partial, not automatic.
• Low testosterone in men is often driven by obesity ("metabolic hypogonadism"), which ties it back to the same metabolic web as the rest of ED.
• Testosterone treatment is not a general ED cure - it helps men who are genuinely deficient, but given to men with normal levels it won't fix ED.

So while "low T" is a real contributor worth checking, it's not the dominant cause the way it's sometimes marketed. The sensible approach is a blood test (ideally a morning sample) when symptoms suggest it, and a clinician's judgment - not an assumption that ED automatically means low testosterone. Our guide on whether low testosterone causes ED covers the nuance, including the newer evidence on metabolic routes to raising it.

Pulling the statistics together, here's roughly how the major ED risk factors stack up - though they overlap heavily and cluster in the same men, so "ranking" them is approximate. This is the data of this whole guide, distilled:

Two honest caveats. First, these figures come from different studies with different methods, so they aren't directly comparable - read them as "all of these meaningfully raise risk," not as a precise league table. Second, and more usefully: notice how many are modifiable. Age isn't, but diabetes control, weight, smoking, fitness, mental health and medication choices all are. The risk-factor data isn't just depressing statistics - it's a to-do list. The same choices that lower nearly every number in that table also protect your heart, which is the real prize.

Despite how common and treatable ED is, a large share of men never seek help - studies and clinicians consistently report that only a minority of affected men get formal treatment, with embarrassment, stigma and the false belief that nothing can be done as the main barriers. This is the gap between how common ED is and how often it's addressed - and it's the statistic most worth changing.

What the picture looks like:

• ED is one of the most under-reported and under-treated common conditions in men's health - many men wait years, or never go at all.
• The barriers are consistent: embarrassment and stigma, the assumption that ED is an untreatable part of aging, not knowing how easy treatment now is, and reluctance to discuss it with a doctor face-to-face.
• This under-treatment persists even though effective, affordable, discreet treatment exists and helps the large majority of men.

This is exactly where the rise of telehealth has made a real difference: by removing the most awkward barrier - the in-person conversation - online treatment has brought help within reach of men who'd otherwise have suffered in silence. The honest message behind this statistic is simple and hopeful: if you're one of the many men with untreated ED, you're leaving an easy, effective solution on the table. You can start privately and online - see how it works in our guide to getting ED treatment online, or compare licensed clinics on our ED treatment comparison.

The under-treatment gap comes down to a few consistent, very human reasons: embarrassment, the myth that ED is an untreatable part of aging, fear of what it might mean, and - historically - the hassle and awkwardness of an in-person visit. Understanding the barriers is the first step to getting past them.

The recurring reasons men give (and the honest counter to each):

• Embarrassment / stigma. ED feels tied to masculinity and identity, so men hide it. But it's a common medical issue, not a character flaw - clinicians have these conversations constantly.
• "Nothing can be done / it's just aging." False - ED is highly treatable at every age, and treating it is often straightforward.
• Fear. Some men avoid finding out there's a health problem. But because ED can be an early warning sign, finding out early is an advantage, not a threat.
• Access and awkwardness. The old model meant a face-to-face appointment many men dreaded - a barrier telehealth has largely removed.
• Relationship avoidance. Men withdraw rather than talk, which worsens both the relationship and the anxiety.

None of these barriers reflect the reality, which is that ED is common, usually treatable, sometimes a useful health signal, and now easy and private to address. The statistics on under-treatment aren't a story about ED being hopeless - they're a story about stigma costing men easy solutions. Changing that for yourself starts with a single low-stakes step: a private online evaluation. It's the opposite of the dreaded appointment, and it's where most men's ED problem actually gets solved.

This is the number that matters most, and it's the most hopeful one in the entire guide: erectile dysfunction is treatable for the large majority of men. First-line PDE5 inhibitor pills (sildenafil, tadalafil) help most men who take them, and when they aren't enough, there's a well-established ladder of further options that works for nearly everyone. Every sobering prevalence statistic in this article sits under this reassuring one.

Why the outlook is so good:

• PDE5 inhibitors - the proven first-line treatment - help a large majority of men across causes, and generics cost very little.
• When pills aren't enough, further options (dose adjustments, combination or compounded treatments, injections, vacuum devices, and ultimately implants) resolve the great majority of remaining cases.
• Many cases, especially in younger men, improve by addressing the cause - lifestyle, mental health, medication review - sometimes without ongoing treatment at all.
• ED is, in treatment terms, one of the most solvable conditions in men's health.

So here's the honest framing of all the data together: ED is extremely common, rises with age, and is tightly linked to overall health - and it is also highly treatable, often easily and affordably, for almost everyone who seeks help. The prevalence numbers are a reason to normalize the condition and get evaluated; the treatability number is the reason there's no good reason to suffer with it. If you want to see the proven options, start with our best ED treatment guide or compare licensed clinics on our ED treatment comparison.

ED isn't only a physical statistic - it has a measurable impact on mental health, confidence, relationships and quality of life for both men and their partners, which is part of why treating it matters beyond the mechanics. The numbers on prevalence tell only half the story; the human impact is the other half.

What the research and clinical experience consistently show:

• ED is strongly associated with reduced self-esteem, anxiety and depression - and the relationship runs both ways, each worsening the other.
• It affects partners and relationships, sometimes causing misunderstanding (a partner may wrongly read it as lost attraction), withdrawal and tension - which is why communication is so central to resolving it.
• Untreated ED can lead men to avoid intimacy entirely, compounding relationship strain.
• Successfully treating ED typically improves not just sexual function but mood, confidence and relationship satisfaction.

This is why the under-treatment statistic is more than a medical footnote - the cost of leaving ED untreated isn't just the physical symptom, it's the accumulating toll on confidence and connection. And it's why the reassuring treatability number is so valuable: resolving ED often lifts the whole picture, not just the bedroom. If ED is affecting your relationship, honesty with your partner - counterintuitive as it feels - is one of the most effective first moves, and treatment handles the rest. The data is clear that men who address ED tend to get back far more than reliable erections.

The scale of ED as a condition is matched by the scale of the market around it: erectile dysfunction treatment is a multi-billion-dollar global industry, driven by huge prevalence, the arrival of cheap generics, and the explosion of telehealth. The economics are worth understanding because they shape what you see and pay.

A few honest observations about the market:

• With hundreds of millions of men affected worldwide, ED treatment is a very large global market spanning branded and generic pills, compounded products, devices and procedures.
• The shift to generic sildenafil and tadalafil dramatically lowered the price of proven treatment - good news for consumers, even as it reshaped the branded market.
• Telehealth transformed access and competition, making discreet online treatment the default route for many men and intensifying price competition.
• The same large, motivated, discreet market also attracts heavy marketing of unproven or overpriced options - from "male enhancement" supplements to high-cost procedures - which is why evidence and price-comparison matter so much.

The practical lesson from the economics: the sheer size of the market means both that proven treatment is now cheap and accessible, and that there's a lot of marketing noise around it. Being a smart consumer - favoring proven, affordable, licensed options and treating bold claims skeptically - is how you benefit from the good side of this market and avoid the bad. Our ED treatment cost guide and ED Cost Index break down what things actually cost.

If you've noticed ED prevalence figures ranging from 3% to over 76%, you're not imagining it - that enormous spread comes down to three things: how studies define ED, how they measure it, and who they study. There is no single "true" number, which is why honest statistics come with ranges. Understanding this makes you a far better reader of any ED statistic.

The main reasons the numbers diverge:

• Definition. A study counting "any difficulty, ever" will report a much higher figure than one counting only "moderate-to-complete, persistent" ED. This single choice can double or halve the result.
• Measurement. Self-report questionnaires (like the MMAS item or the IIEF) differ, and self-reported sexual function is sensitive to wording, mood and honesty.
• Population. A study of 20-40 year-olds and a study of 60-80 year-olds will report wildly different prevalence - and clinic-based samples (men seeking help) run higher than general-population samples.
• Geography and era. Different countries, cultures and decades produce different figures.

This is exactly why this guide gives ranges and names its sources rather than pretending there's one clean number. When you see a confident single statistic quoted anywhere - "X% of men have ED" - the right questions are: which severity, measured how, in whom? The most trustworthy takeaways are the robust patterns that hold across studies despite the noise: ED is common, rises steeply with age, and tracks vascular and metabolic health. Those conclusions are solid even when the exact percentages aren't.

ED statistics come almost entirely from self-report questionnaires - men answering standardized questions about their erectile function - most commonly the single MMAS item or the more detailed International Index of Erectile Function (IIEF). There's no blood test or scan for population-level ED, which is both practical and a source of the measurement variability. Knowing how the sausage is made helps you weigh the numbers.

The main tools behind the data:

• The MMAS self-report item classifies men as having no, minimal, moderate or complete ED based on their own description of their function. Simple, widely used, and the basis for much classic prevalence data (including NHANES, which adopted it).
• The IIEF (and its short form, the IIEF-5 or "SHIM") is a more detailed questionnaire scoring erectile function across several questions - the standard tool in clinical trials and many studies.
• Both rely on honest self-report, which is practical at scale but introduces subjectivity - men may under- or over-report, and definitions of "satisfactory" differ.

This is why ED prevalence is genuinely an estimate, not a precise count - it's built from men's own accounts, filtered through different questionnaires and thresholds. That's not a flaw to dismiss the data over; self-report is the appropriate and standard method for a condition defined by personal experience. But it does mean the honest way to present ED statistics is with ranges and named sources - which is how this guide has tried to do it throughout.

Strip away the percentages and the practical message is simple and reassuring: if you have ED, you're part of a very large, very normal group of men - and an even larger group whose ED is treatable. The statistics are a reason to normalize the condition and act on it, not to worry. Here's how to translate the data into your own situation.

What the numbers mean personally:

• You're not alone or abnormal. ED is common at every age and the majority experience among older men. Whatever shame you might feel, the data says this is ordinary.
• It may be a useful signal. Because ED tracks vascular and metabolic health - and can precede heart problems - new ED is a good reason to get your blood pressure, blood sugar and cholesterol checked. That's an opportunity, not a threat.
• The cause usually points to the fix. Younger and stressed? Often psychological or lifestyle. Older with risk factors? Often vascular. Diabetic or overweight? Often metabolic. The cause determines the treatment.
• The most important statistic is on your side. ED is treatable for the large majority of men - and most of the under-treatment is just men not asking for help that works.

So the right response to "how common is ED?" isn't resignation - it's action. Get evaluated, address the cause, use proven treatment, and know that the odds are strongly in your favor. You can start privately and online: compare vetted, licensed clinics on our ED treatment comparison, or read our top-rated pick in the DirectMeds review.

ED is common everywhere it's been studied, but reported prevalence varies widely between countries and regions - partly real variation driven by differing rates of diabetes, obesity and smoking, and partly an artifact of different study methods and definitions. There's no clean global league table, but some patterns emerge.

What the global data broadly shows:

• Prevalence estimates span an enormous range across countries - a review found figures from as low as 3% to as high as 76.5% - largely reflecting differences in the ages studied and how ED was measured, not just true national differences.
• Regions with higher rates of the metabolic risk factors (diabetes, obesity) tend toward higher ED burden, which is one reason the condition is a growing concern in rapidly-developing economies.
• Cultural factors affect the reporting as much as the reality - in places where discussing sexual health is more taboo, under-reporting likely makes figures look lower than the truth.

The honest takeaway is that ED is a genuinely global condition affecting hundreds of millions of men across every region, with the exact national percentages too method-dependent to rank reliably. What travels across borders is the underlying biology: wherever vascular and metabolic disease rise, ED rises with them. That also means the global trajectory is tied to the global trajectory of diabetes and obesity - which is not encouraging for prevalence, but does point, again, at the same modifiable health factors as the solution.

The relationship between alcohol and ED is dose-dependent: light-to-moderate drinking isn't clearly linked to ED (and some studies even find a slightly lower risk), but heavy and chronic drinking is associated with higher rates of erectile dysfunction. "Alcohol causes ED" is too simple; "too much alcohol contributes to ED" is accurate.

The picture from the research:

• In the moment, alcohol is a depressant that dampens the nervous-system signals needed for an erection - the classic "brewer's droop."
• Chronically, heavy drinking can lower testosterone, damage nerves and blood vessels, and contribute to lasting ED.
• Moderate intake hasn't shown a clear harmful association in much of the research - some studies even suggest a modest protective pattern, though this is debated and shouldn't be read as a reason to drink.

So the honest statistic isn't a scary single number - it's a J-shaped-ish relationship where the problem is quantity. For a man with ED who drinks heavily, cutting back is a reasonable, no-cost experiment that often helps within weeks. It also ties into the broader theme of this guide: the lifestyle factors that drive ED statistics (alcohol, smoking, inactivity, weight) are largely modifiable, and addressing them improves both the erectile numbers and overall health. Recreational drugs follow a similar pattern - several (including cocaine, opioids and heavy cannabis use) are associated with higher ED rates.

ED is one of the most common side effects of prostate cancer treatment. Rates after radical prostatectomy (prostate removal) vary widely depending on the surgery, the surgeon, the man's age and his baseline function - but ED is common enough that it's a central part of prostate-cancer counseling. This is a distinct, important slice of ED statistics.

What's known:

• ED is very common after radical prostatectomy, because the surgery can damage or stress the nerves that trigger erections - even with nerve-sparing technique.
• Reported recovery rates vary enormously (from a minority to a majority regaining function) depending on nerve-sparing, the man's age, his erectile function before surgery, and how recovery is measured and supported.
• Radiation therapy for prostate cancer also causes ED in a substantial share of men, though often with a more gradual onset than surgery.
• ED from these treatments is largely nerve-related, which is a different problem than the vascular ED that dominates the general population.

This matters for treatment choice: because post-surgical ED is nerve-related, the evidence-based options differ (penile rehabilitation protocols, PDE5 inhibitors, injections like Trimix, vacuum devices, and ultimately implants), and some treatments marketed for general ED - like shockwave therapy - don't have good evidence in this group. If you're facing or recovering from prostate-cancer treatment, erectile recovery is a specialist (urology) conversation, and it's one worth having proactively rather than waiting.

Obstructive sleep apnea is strongly associated with erectile dysfunction - studies consistently find ED is more common in men with sleep apnea than in those without - making it an often-missed contributor worth checking. It's one of the less-obvious entries in the ED-statistics picture.

Why the two are linked:

• Sleep apnea - where the airway repeatedly collapses during sleep - is far more common in men with obesity, tying it to the same metabolic web as much ED.
• Fragmented sleep and repeated drops in oxygen disrupt the hormonal rhythms that produce testosterone (much of which is made during sleep), strain the cardiovascular system, and cause chronic fatigue - all bad for erectile function.
• Studies report ED is substantially more prevalent in men with diagnosed sleep apnea, and treating the apnea can improve erectile function in some men.

The practical point is that a man with ED who snores heavily, wakes unrefreshed, or has been told he stops breathing in his sleep should consider getting evaluated for sleep apnea - it's a treatable condition with benefits far beyond erections (cardiovascular health, energy, mood). It's a good example of how ED statistics connect to overall health: the same thing hurting a man's sleep and heart may also be behind his ED, and fixing it helps across the board. If weight is involved, our guide on metabolic health and erections covers the wider connections.

The data consistently favors the active: physically active men have lower rates of erectile dysfunction, and sedentary men have higher rates - and exercise has been shown to improve erectile function, making it one of the best-evidenced lifestyle interventions for ED. If there were a "free ED treatment with the strongest data," regular exercise would be a leading candidate.

What the research supports:

• Men who are regularly physically active have a meaningfully lower risk of ED than sedentary men - exercise improves the vascular and endothelial health erections depend on.
• Both aerobic exercise (which directly benefits blood flow) and resistance training (which supports testosterone and body composition) contribute.
• Intervention studies, including the landmark weight-loss-and-activity trial, found that increasing physical activity was independently associated with improved erectile function - not just as a side effect of weight loss.
• The benefit is dose-related within reason: more regular moderate activity, better results - though the overtraining extreme can backfire.

This is genuinely one of the most encouraging statistics in the whole topic, because it's actionable, free, and improves everything else. A man who gets and stays active is working directly on the vascular health that underlies most ED - compensating for, or even reversing, some of the risk the other statistics describe. It won't override a medication side effect or a significant psychological block on its own, but as a foundation it's powerful. Our natural ED remedies guide covers the exercise evidence in depth.

A meaningful share of ED is medication-related. The drugs most consistently associated with erectile dysfunction include certain blood-pressure medicines (older diuretics and beta-blockers), antidepressants (especially SSRIs), the hair-loss drug finasteride, and anabolic steroids - among others. Medication-induced ED is common enough to always be worth reviewing, because it's often reversible.

The notable offenders:

• Antidepressants (SSRIs) - sexual dysfunction, including ED and lowered libido, is one of their most common side effects, affecting a large share of users.
• Certain blood-pressure drugs - older thiazide diuretics and beta-blockers are the classic culprits, while other classes (ACE inhibitors, ARBs) are more erection-neutral.
• Finasteride - the hair-loss and prostate drug lists ED and reduced libido as side effects, and a debated minority report persistent symptoms.
• Anabolic steroids - suppress the body's own testosterone, commonly causing ED, especially after a cycle.
• Others include some antihistamines, antipsychotics and opioids.

The important, hopeful point: medication-induced ED is frequently reversible by adjusting, switching or (under medical guidance) stopping the drug - but you should never stop a prescribed medication on your own. If your ED began after starting a new drug, that timing is a strong clue worth bringing to your prescriber, who usually has alternatives. Our guide to ED medication side effects covers the treatment side, and the medication-cause angle is explored in our young men's ED guide, where SSRIs and finasteride are common causes.

Healthy men typically have several involuntary erections during sleep and on waking - so the presence of regular morning erections suggests the physical erectile machinery is working, while their consistent absence can be a clue that ED has an organic (physical) cause. It's one of the most useful self-assessment signals in the whole topic.

How clinicians read it:

• Men normally experience several nocturnal erections per night, often noticed as a morning erection - a sign the nerves and blood vessels are functioning.
• Preserved morning/spontaneous erections, plus erections during masturbation, alongside difficulty with a partner, point toward a psychological cause (the hardware works; the signal is being blocked by anxiety or stress).
• A gradual loss of morning and spontaneous erections, consistent across all situations, points more toward an organic (physical/vascular) cause worth investigating.

This is why "do you still get morning erections?" is one of the first questions a good clinician asks - it helps sort psychological from physical ED without any testing. It's not definitive on its own (the overlap is real), but it's a genuinely useful signal you can observe yourself. If you've lost your morning erections along with partnered function, that's a reason to get evaluated rather than assume it's "in your head." If you still get them reliably but struggle with a partner, the cause is more likely psychological - and often very treatable, as our guide to ED in young men explains.

They're different conditions, and in younger men, premature ejaculation (PE) is often cited as the more common sexual complaint - frequently estimated to affect around 20-30% of men - while ED becomes relatively more common with age. The two get confused constantly, so it's worth separating them in the statistics.

The distinction:

• Erectile dysfunction (ED) is difficulty getting or keeping an erection - the issue is the erection itself. Prevalence rises steeply with age.
• Premature ejaculation (PE) is reaching orgasm sooner than wanted - the erection may be perfectly fine; the timing of climax is the problem. PE is frequently described as the most common male sexual dysfunction overall, and is especially common in younger men.
• Low libido (reduced desire) is a third, separate issue, more tied to hormones, mood and relationship factors.

They can overlap and feed each other - anxiety about PE can morph into performance anxiety that causes ED, and depression can cause both - but the treatments differ, so getting the category right matters. A PDE5 inhibitor treats ED, not PE. If you're unsure which you have, describing the specifics accurately to a clinician - is it the erection, the timing of climax, or the interest? - is what lets them help. The key statistical point: don't assume your issue is ED just because it's the one people talk about; in a younger man, PE is statistically at least as likely.

The arrival of Viagra (sildenafil) in 1998 transformed ED from a rarely-discussed, hard-to-treat condition into one of the most openly-discussed and easily-treated in men's health - dramatically increasing both diagnosis and treatment, and arguably making ED prevalence "look" higher simply because far more men now report it. It's a reminder that statistics reflect behavior, not just biology.

What changed:

• Before 1998, effective oral ED treatment barely existed, and the condition was heavily stigmatized and under-discussed. Treatment meant injections, devices or surgery.
• Viagra's launch - and the blockbuster marketing around it - normalized the conversation, prompting millions of men to seek help who never would have before.
• This increased diagnosis and treatment rates enormously, which can look like rising prevalence even where the underlying rate was stable.
• The later arrival of cheap generics (sildenafil and tadalafil) and telehealth extended that shift, making proven treatment affordable and private.

The lesson for reading ED statistics across time is that some apparent "increases" reflect men finally reporting and treating a condition they'd previously hidden - a good thing, even if it inflates the numbers. The flip side: despite this transformation, a large share of men still don't seek help. So while the Viagra era hugely improved access and openness, the under-treatment gap this guide keeps returning to still exists - which is exactly the gap telehealth is now closing.

Some studies have reported an association between COVID-19 infection and a higher likelihood of erectile dysfunction - with proposed mechanisms including COVID's effects on blood vessels, inflammation, testosterone and mental health - though the evidence is still developing and causation isn't firmly established. It's a newer, much-discussed entry in the ED-statistics conversation, worth reporting honestly with its uncertainty.

What the emerging research suggests:

• Several studies found men who had COVID-19 reported higher rates of ED than those who hadn't, prompting the (somewhat sensational) framing of ED as a possible COVID complication.
• Plausible mechanisms: COVID is known to affect the endothelium (blood-vessel lining) and cause inflammation and clotting issues - and healthy endothelium is essential for erections. It may also affect testosterone and, via the broader toll of illness, mental health.
• The caveats are significant: much of the data is observational and early, confounding is hard to rule out (men who got sicker may differ in other ways), and the long-term picture is unclear.

The honest read: there appears to be a real signal linking COVID infection to erectile problems in some men, consistent with COVID's known vascular effects, but it's early evidence and shouldn't be overstated. For most men, if ED developed around or after a COVID infection, the sensible response is the same as for any new ED - get evaluated, because the cause (whatever it is) is usually treatable, and new ED can be a signal worth checking regardless of the trigger.

Tens of millions of men worldwide take ED medication, and sildenafil and tadalafil are among the most-prescribed drugs in their class - but, tellingly, the number who take treatment is still far lower than the number who have ED, reflecting the persistent under-treatment gap. The prescription statistics are large and yet smaller than they should be.

What the usage picture shows:

• PDE5 inhibitors (sildenafil, tadalafil, and others) are among the most widely-used medications of their type, with tens of millions of men using them globally since their introduction.
• The shift to cheap generics and telehealth has expanded access considerably, pushing usage up.
• Yet the number of men treating their ED remains well below the number experiencing it - the under-treatment gap this guide keeps returning to.
• A real, if hard-to-quantify, share of pills are also obtained through illegitimate channels (no-prescription sites), which is dangerous - see our guide to getting ED meds without a prescription for why.

The usage statistics, like the prevalence ones, tell a two-part story: ED treatment is enormously common and increasingly accessible, and yet a large group of men who could benefit still aren't being treated (or are using risky unregulated sources). The encouraging interpretation is that there's a lot of room for men to move from the "has ED, untreated" column to the "treating it safely and effectively" column - which, given how well treatment works, is simply a better place to be.

Sometimes - ED can resolve on its own, especially when the cause is temporary (stress, a short course of a medication, excess alcohol, a bout of poor sleep) or psychological - but persistent ED with an underlying physical cause usually doesn't disappear without addressing that cause. The honest answer is "it depends entirely on the cause."

How it tends to go by cause:

• Situational / temporary causes (a stressful period, a new relationship's nerves, too much alcohol one night, a passing medication) often resolve on their own once the trigger passes - a single off night is not ED.
• Psychological ED can resolve as the anxiety or depression driving it is addressed - and short-term treatment can speed that by breaking the cycle.
• Lifestyle-driven ED often improves - sometimes quickly - when the input changes (quitting smoking, losing weight, cutting alcohol, fixing sleep).
• Vascular / organic ED tied to age, diabetes or heart disease generally does not spontaneously resolve and tends to persist or progress without treatment and risk-factor management.

So the "will it go away?" question is really "what's causing it?" - and that's exactly why evaluation matters rather than waiting and hoping. The good news baked into all of this: even the ED that won't resolve on its own is highly treatable. Waiting months in silence to see if it passes is usually the wrong move - both because a treatable cause goes unaddressed, and because new ED can be an early health signal worth catching. Our guide on what causes ED helps you think through the likely cause.

The most common clinical tool for scoring ED severity is the IIEF-5 (also called the Sexual Health Inventory for Men, or SHIM) - a five-question survey where a lower score means more severe ED. Understanding the bands helps you make sense of ED statistics and your own situation. Here's how the scoring works, as a useful reference.

The IIEF-5 asks five questions about erectile function over the past six months, each scored, for a total between 5 and 25. The standard severity bands are:

Why this is worth knowing: when a study or clinic reports ED prevalence or "improvement," it's often using scores like these - so "a 4-point improvement on the IIEF" means something concrete once you see the bands. It also explains why the choice of threshold matters so much to prevalence figures: a study counting everyone scoring 21 or below (mild and up) will report far more "ED" than one counting only scores of 11 or below (moderate-to-severe). Many online versions of this questionnaire exist, but a score is a starting point for a conversation with a clinician, not a diagnosis on its own - the number guides treatment, it doesn't replace a proper evaluation.

Some studies report differences in ED prevalence across racial and ethnic groups, but the data is limited, inconsistent, and heavily confounded by differences in the underlying health conditions (like diabetes and hypertension) that actually drive ED - so any apparent differences are hard to interpret and shouldn't be over-read. This is an area where honesty about the limits of the data matters.

What can fairly be said:

• Where studies report differences, they largely track differences in the prevalence of risk factors - diabetes, high blood pressure, obesity, cardiovascular disease - rather than pointing to race itself as a cause.
• Access to care, socioeconomic factors and willingness to report all affect the numbers, making clean comparisons difficult.
• The underlying biology of ED is the same across groups: it's a vascular, metabolic, hormonal and psychological condition, and the same risk factors and treatments apply.

The responsible interpretation is that ED's real drivers are the modifiable health conditions it's tied to, which vary between populations for many reasons - not an intrinsic difference in erectile biology. For any individual man, race and ethnicity don't change the approach: identify the cause, manage the risk factors, use proven treatment. If anything, the useful takeaway is that groups with higher rates of diabetes and cardiovascular disease have more reason to take new ED seriously as a potential health signal - which, again, points back to evaluation and the modifiable risk factors at the center of this whole guide.

You should pay attention to ED - not panic, but act - when it's persistent (a consistent pattern over weeks rather than a single off night), when it comes with other symptoms, when you have cardiovascular risk factors, or when it's distressing you. Given how common and treatable ED is, the real risk isn't the ED itself; it's ignoring it. Here's how to calibrate concern against the statistics.

Reasons to get evaluated (rather than wait):

• A persistent pattern rather than the occasional off night - the latter is normal and not ED.
• ED alongside other symptoms - chest discomfort, severe fatigue, low libido, mood changes, or signs of low testosterone.
• You have cardiovascular risk factors (high blood pressure, diabetes, high cholesterol, smoking, family history) - because new ED can be an early vascular warning sign.
• A sudden, complete change that coincides with a new medication.
• It's causing you distress or relationship strain - that alone is reason enough.

Set against the statistics, the message is balanced: ED is so common that having it is nothing to catastrophize about, but it's also tied closely enough to overall health - and so treatable - that it's worth addressing rather than enduring. The worst outcome in the data isn't a man who has ED; it's a man who has treatable ED (and possibly an early health signal) and does nothing about it for years out of embarrassment. The low-stakes first step is a private online evaluation - the opposite of the dreaded appointment, and where most men's ED actually gets solved. Compare licensed clinics on our ED treatment comparison.

PDE5 inhibitor pills - the first-line treatment - work for a large majority of men, with response rates commonly reported in the range of roughly 60-70% across causes, and higher in men with milder or psychological ED. This is the statistic that turns the sobering prevalence numbers into good news.

What the effectiveness data broadly shows:

• PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) help a large majority of men who take them - commonly cited response rates land around two-thirds or more, varying by the cause and severity of the ED.
• Response is higher in men with milder ED, psychological causes, or fewer vascular risk factors; lower in men with severe ED, significant nerve damage (such as after prostate surgery), or poorly-controlled diabetes.
• Men who don't respond at first often improve with a dose adjustment, a different pill, correct usage (timing, on an empty stomach for sildenafil), or by addressing an underlying factor - so "the first pill didn't work" rarely means "nothing will."
• When pills genuinely aren't enough, second-line options (injections, vacuum devices) and ultimately implants resolve the great majority of remaining cases.

Put together, the treatment-success statistics are why the honest bottom line of this entire guide is optimistic: ED is common, but it's also one of the most treatable conditions in men's health. The majority respond to a cheap, proven first-line pill, and nearly everyone else can be helped with the next steps. If the prevalence numbers are the "you're not alone" message, the effectiveness numbers are the "and you can fix it" message. See the options in our best ED treatment guide.

This is one of the most-searched and most-contested questions in the ED-statistics space, and honesty requires saying: the idea that pornography causes ED ("porn-induced ED") is a real hypothesis supported by some clinical reports, but it is scientifically debated and not established by solid prevalence data. Be skeptical of confident statistics in either direction here.

What's fair to say about the data:

• Some researchers and clinical reports suggest that heavy, high-novelty internet pornography use may contribute to erectile difficulty with a real partner in a subset of men - and that reducing use sometimes helps.
• But other studies and reviews have found little solid evidence that pornography use induces ED, and the research is largely correlational with no controlled trials.
• Heavy porn use often travels with other ED-relevant factors (anxiety, depression, relationship issues), making cause and effect genuinely hard to separate.
• "Porn-induced ED" is not a formal medical diagnosis, and reliable prevalence figures for it don't exist.

So any statistic claiming "X% of ED is caused by porn" should be treated with caution - the honest state of the evidence doesn't support a firm number. For an individual man whose erections are fine solo but unreliable with a partner, and who uses porn heavily, reducing use is a reasonable, low-risk experiment - but it shouldn't distract from the better-evidenced causes. We cover this debate in full, without taking a side beyond what the evidence supports, in our guide to ED in young men.

Testosterone replacement therapy (TRT) has surged in popularity in recent years, often marketed heavily to men with ED - but the statistics come with an important caveat: low testosterone is a less common primary cause of ED than marketing implies, and TRT is not a general ED treatment. The usage trend and the evidence don't fully line up.

What's happening:

• TRT prescriptions and cash-pay "low-T clinic" use have grown substantially, driven partly by aggressive direct-to-consumer marketing that often links low testosterone to ED.
• But many men with ED have normal testosterone, and many men with low testosterone have normal erections - the overlap is partial, and low-T more often reduces libido than directly causing a mechanical erection failure.
• TRT helps men who are genuinely deficient, but given to men with normal levels it won't fix ED - and it carries its own trade-offs (including suppressing natural production and fertility).
• Low testosterone in men is frequently driven by obesity, tying it back to the same metabolic roots as the rest of ED.

The honest statistical point is that the TRT boom outpaces the evidence that low testosterone is driving most ED. If low-T symptoms are present (low libido, fatigue, low mood alongside ED), a blood test and a clinician's judgment are the right path - not an assumption that ED means you need testosterone. Our guide on whether low testosterone causes ED covers the nuance, including newer evidence on metabolic routes to raising it.

Beyond prevalence, ED carries a real cost - to individual quality of life, mental health and relationships, and collectively to healthcare systems and productivity - which is part of why it's taken seriously as a public-health issue, not just a private inconvenience. The human and economic statistics round out the picture.

The costs the data points to:

• Quality of life and mental health: ED is consistently associated with lower self-esteem, higher anxiety and depression, and reduced relationship satisfaction - for men and their partners.
• A marker of costly disease: because ED is an early warning sign of cardiovascular disease, it flags men at higher risk of expensive, serious conditions - meaning its real "cost" includes the downstream heart disease it can predict.
• A large treatment market: ED treatment is a multi-billion-dollar global industry, reflecting both the scale of the condition and the demand for solutions.
• Hidden costs of under-treatment: the men who don't seek help bear uncounted costs in wellbeing and relationships that never show up in a prescription statistic.

The constructive way to read the cost data is that treating ED pays off well beyond the bedroom: it improves mood, confidence and relationships, and the evaluation that comes with it can catch cardiovascular risk early - potentially averting far costlier health problems down the line. In other words, the "cost of ED" is largely a cost of untreated ED - which, given how treatable the condition is, is a largely avoidable one. That's the recurring theme of every statistic in this guide.

The outlook is for ED to become more common, not less - driven by aging populations and, especially, the global rise in the metabolic conditions (obesity, type 2 diabetes) that cause it - even as awareness, diagnosis and treatment access keep improving. The prevalence trend lines point up, which makes the treatability story all the more important.

The forces shaping the next several years:

• Aging populations. Since ED rises steeply with age, populations getting older means more ED, all else equal.
• Rising metabolic disease. Obesity and type 2 diabetes - two of the strongest ED risk factors - continue to climb globally and appear in younger people, which likely pushes both overall and younger-men prevalence up.
• More recognition and treatment. On the positive side, telehealth, generics and destigmatization keep expanding access, so more of the men who have ED will actually be treated - a trend that improves lives even as it makes prevalence more visible.
• Possible new treatments may expand options, though the proven first-line (PDE5 pills plus addressing the cause) will likely remain the backbone.

The honest synthesis: ED is common now and will probably be more common in the years ahead, chiefly because the conditions that cause it are rising. But that makes the two most actionable themes of this guide more important, not less - that ED is highly treatable, and that the same modifiable health factors driving the prevalence numbers (weight, blood sugar, fitness, smoking) are within individual control. The prevalence trend is a reason to take metabolic health seriously, for your erections and everything else.